Literature DB >> 19038299

Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations.

Kaili Hu1, Jingwei Li, Yehong Shen, Wei Lu, Xiaoling Gao, Qizhi Zhang, Xinguo Jiang.   

Abstract

The lactoferrin (Lf) conjugated poly (ethyleneglycol)-poly (lactide) nanoparticle (Lf-NP) was constructed in this paper as a novel biodegradable brain drug delivery system with evaluation of its in vitro and in vivo delivery properties. Lf was thiolated and conjugated to the distal maleimide functions surrounding on the pegylated nanoparticles to form the Lf-NP. The existence of Lf on the surface of Lf-NP was verified by TEM observation and XPS analysis. The Lf ELISA results confirmed the biorecognitive activity of Lf after the coupling procedure and suggested the average number of Lf conjugated on each nanoparticle was around 55. To evaluate the brain delivery properties of the Lf-NP, a fluorescent probe, coumarin-6 was incorporated into it. The uptake of Lf-NP by bEnd.3 cells was shown significantly higher than that of unconjugated nanoparticle (NP). Following an intravenous administration, a near 3 folds of coumarin-6 were found in the mice brain carried by Lf-NP compared to that carried by NP. Cell viability experiment results confirmed good safety of the biodegradable Lf-NP. The significant in vitro and in vivo results suggest that Lf-NP is a promising brain drug delivery system with low toxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038299     DOI: 10.1016/j.jconrel.2008.10.016

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  62 in total

Review 1.  Nanoparticulate systems for drug delivery and targeting to the central nervous system.

Authors:  Emanuela Fabiola Craparo; Maria Luisa Bondì; Giovanna Pitarresi; Gennara Cavallaro
Journal:  CNS Neurosci Ther       Date:  2010-10-15       Impact factor: 5.243

Review 2.  Nano-enabled delivery of diverse payloads across complex biological barriers.

Authors:  Kathleen A Ross; Timothy M Brenza; Andrea M Binnebose; Yashdeep Phanse; Anumantha G Kanthasamy; Howard E Gendelman; Aliasger K Salem; Lyric C Bartholomay; Bryan H Bellaire; Balaji Narasimhan
Journal:  J Control Release       Date:  2015-08-24       Impact factor: 9.776

3.  Traceable microRNA-124 loaded nanoparticles as a new promising therapeutic tool for Parkinson's disease.

Authors:  Cláudia Saraiva; Lino Ferreira; Liliana Bernardino
Journal:  Neurogenesis (Austin)       Date:  2016-11-14

4.  Comparison of Blood-Brain Barrier Models for in vitro Biological Analysis: One Cell Type vs Three Cell Types.

Authors:  Yang Song; Xiaoli Cai; Dan Du; Prashanta Dutta; Yuehe Lin
Journal:  ACS Appl Bio Mater       Date:  2019-01-25

5.  Core-shell Structure and Aggregation Number of Micelles Composed of Amphiphilic Block Copolymers and Amphiphilic Heterografted Polymer Brushes Determined by Small-Angle X-ray Scattering.

Authors:  Magdalena Szymusiak; Joseph Kalkowski; Hanying Luo; Alexander J Donovan; Pin Zhang; Chang Liu; Weifeng Shang; Thomas Irving; Margarita Herrera-Alonso; Ying Liu
Journal:  ACS Macro Lett       Date:  2017-08-31       Impact factor: 6.903

Review 6.  Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.

Authors:  Sonu Bhaskar; Furong Tian; Tobias Stoeger; Wolfgang Kreyling; Jesús M de la Fuente; Valeria Grazú; Paul Borm; Giovani Estrada; Vasilis Ntziachristos; Daniel Razansky
Journal:  Part Fibre Toxicol       Date:  2010-03-03       Impact factor: 9.400

Review 7.  Polymersome-based drug-delivery strategies for cancer therapeutics.

Authors:  Tayebeh Anajafi; Sanku Mallik
Journal:  Ther Deliv       Date:  2015

8.  Enhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation.

Authors:  Hong Ding; Vidya Sagar; Marisela Agudelo; Sudheesh Pilakka-Kanthikeel; Venkata Subba Rao Atluri; Andrea Raymond; Thangavel Samikkannu; Madhavan P Nair
Journal:  Nanotechnology       Date:  2014-01-09       Impact factor: 3.874

Review 9.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors:  Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2019-09-14       Impact factor: 12.479

10.  The use of borneol as an enhancer for targeting aprotinin-conjugated PEG-PLGA nanoparticles to the brain.

Authors:  Lin Zhang; Limei Han; Jing Qin; Weiyue Lu; Jianxin Wang
Journal:  Pharm Res       Date:  2013-04-25       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.